Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32.570
Filtrar
1.
AMA J Ethics ; 26(7): E527-533, 2024 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-38958421

RESUMO

Evidence of harm reduction interventions' morbidity and mortality benefits is abundant and of high quality, so there are good reasons for regional and national groups to advocate for more widespread distribution of legally regulated "drug paraphernalia," including needles, syringes, and fentanyl test strips. But lack of consistency among states' laws means that patients' interstate travel can subject them to being charged with possession of illegal items. This commentary on a case offers guidance to clinicians looking to help patients understand legal risks of interstate travel with supplies that are prescribed or recommended to reduce harms of their drug use and explores the ethical responsibilities of physicians in jurisdictions that legally prohibit these harm reduction interventions.


Assuntos
Redução do Dano , Humanos , Redução do Dano/ética , Fentanila , Seringas/ética , Agulhas , Estados Unidos , Equipamentos e Provisões/ética , Equipamentos e Provisões/provisão & distribuição
2.
Health Aff (Millwood) ; 43(7): 979-984, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38950301

RESUMO

The COVID-19 Uninsured Program, administered by the Health Resources and Services Administration (HRSA), reimbursed providers for administering COVID-19 vaccines to uninsured US adults from December 11, 2020, through April 5, 2022. Using HRSA claims data covering forty-two states, we estimated that the program funded about 38.9 million COVID-19 vaccine doses, accounting for 5.7 percent of total doses distributed and 10.9 percent of doses administered to adults ages 19-64.


Assuntos
Vacinas contra COVID-19 , COVID-19 , Pessoas sem Cobertura de Seguro de Saúde , Humanos , Pessoas sem Cobertura de Seguro de Saúde/estatística & dados numéricos , Estados Unidos , COVID-19/prevenção & controle , Adulto , Vacinas contra COVID-19/provisão & distribuição , Vacinas contra COVID-19/economia , Pessoa de Meia-Idade , Feminino , Masculino , United States Health Resources and Services Administration , Adulto Jovem , SARS-CoV-2 , Programas de Imunização/economia
3.
Health Aff (Millwood) ; 43(7): 959-969, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38950300

RESUMO

Global supply chains for active pharmaceutical ingredients (APIs) are highly centralized in certain countries and are susceptible to supply-chain shocks. However, there is no systematic monitoring or global coordination to manage risk and ensure equitable supply continuity during public health emergencies. In this study, we applied quasi-experimental methods on shipment-level customs data to determine how prices and export volume for APIs exported from India were affected by the COVID-19 pandemic. We found that API prices for key essential medicines not used for COVID-19 did not change significantly in the year after the World Health Organization pandemic declaration, but volume decreased by 80 percent. Prices for medicines speculatively repurposed for COVID-19, such as hydroxychloroquine and ivermectin, increased by as much as 250 percent compared with prices for nonrepurposed medicines, but only ivermectin saw a decrease in volume. Systematic monitoring of API markets, investments to promote supply diversification, and legal and political reforms to disincentivize price speculation could support supply-chain resilience and safeguard access to medicines.


Assuntos
COVID-19 , Humanos , COVID-19/epidemiologia , SARS-CoV-2 , Índia , Comércio , Tratamento Farmacológico da COVID-19 , Saúde Global , Medicamentos Essenciais/provisão & distribuição , Medicamentos Essenciais/economia , Ivermectina/provisão & distribuição , Ivermectina/uso terapêutico , Ivermectina/economia , Pandemias , Internacionalidade , Princípios Ativos
4.
Clin Transplant ; 38(7): e15387, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38952190

RESUMO

BACKGROUND: The relationship between age of a heart transplant (HT) program and outcomes has not been explored. METHODS: We performed a retrospective cohort analysis of the United Network for Organ Sharing database of all adult HTs between 2009 and 2019. For each patient, we created a variable that corresponded to program age: new (<5), developing (≥5 but <10) and established (≥10) years. RESULTS: Of 20 997 HTs, 822 were at new, 908 at developing, and 19 267 at established programs. Patients at new programs were significantly more likely to have history of cigarette smoking, ischemic cardiomyopathy, and prior sternotomy. These programs were less likely to accept organs from older donors and those with a history of hypertension or cigarette use. As compared to patients at new programs, transplant patients at established programs had less frequent rates of treated rejection during the index hospitalization (HR 0.43 [95% CI, 0.36-0.53] p < 0.001) and at 1 year (HR 0.58 [95% CI, 0.49-0.70], p < 0.001), less frequently required pacemaker implantations (HR 0.50 [95% CI, 0.36-0.69], p < 0.001), and less frequently required dialysis (HR 0.66 [95% CI, 0.53-0.82], p < 0.001). However, there were no significant differences in short- or long-term survival between the groups (log-rank p = 0.24). CONCLUSION: Patient and donor selection differed between new, developing, and established HT programs but had equivalent survival. New programs had increased likelihood of treated rejection, pacemaker implantation, and need for dialysis. Standardized post-transplant practices may help to minimize this variation and ensure optimal outcomes for all patients.


Assuntos
Transplante de Coração , Humanos , Transplante de Coração/mortalidade , Feminino , Masculino , Estudos Retrospectivos , Pessoa de Meia-Idade , Seguimentos , Taxa de Sobrevida , Adulto , Prognóstico , Obtenção de Tecidos e Órgãos/estatística & dados numéricos , Sobrevivência de Enxerto , Fatores de Risco , Rejeição de Enxerto/mortalidade , Rejeição de Enxerto/etiologia , Complicações Pós-Operatórias/mortalidade , Doadores de Tecidos/provisão & distribuição , Fatores Etários , Idoso
5.
Clin Transplant ; 38(7): e15379, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38952196

RESUMO

BACKGROUND: Introducing new liver transplantation (LT) practices, like unconventional donor use, incurs higher costs, making evaluation of their prognostic justification crucial. This study reexamines the spread pattern of new LT practices and its prognosis across the United States. METHODS: The study investigated the spread pattern of new practices using the UNOS database (2014-2023). Practices included LT for hepatitis B/C (HBV/HCV) nonviremic recipients with viremic donors, LT for COVID-19-positive recipients, and LT using onsite machine perfusion (OMP). One year post-LT patient and graft survival were also evaluated. RESULTS: LTs using HBV/HCV donors were common in the East, while LTs for COVID-19 recipients and those using OMP started predominantly in California, Arizona, Texas, and the Northeast. K-means cluster analysis identified three adoption groups: facilities with rapid, slow, and minimal adoption rates. Rapid adoption occurred mainly in high-volume centers, followed by a gradual increase in middle-volume centers, with little increase in low-volume centers. The current spread patterns did not significantly affect patient survival. Specifically, for LTs with HCV donors or COVID-19 recipients, patient and graft survivals in the rapid-increasing group was comparable to others. In LTs involving OMP, the rapid- or slow-increasing groups tended to have better patient survival (p = 0.05) and significantly improved graft survival rates (p = 0.02). Facilities adopting new practices often overlap across different practices. DISCUSSION: Our analysis revealed three distinct adoption groups across all practices, correlating the adoption aggressiveness with LT volume in centers. Aggressive adoption of new practices did not compromise patient and graft survivals, supporting the current strategy. Understanding historical trends could predict the rise in future LT cases with new practices, aiding in resource distribution.


Assuntos
COVID-19 , Sobrevivência de Enxerto , Transplante de Fígado , SARS-CoV-2 , Humanos , Transplante de Fígado/estatística & dados numéricos , Estados Unidos/epidemiologia , COVID-19/epidemiologia , Feminino , Masculino , Pessoa de Meia-Idade , Obtenção de Tecidos e Órgãos/estatística & dados numéricos , Doadores de Tecidos/provisão & distribuição , Doadores de Tecidos/estatística & dados numéricos , Adulto , Taxa de Sobrevida , Prognóstico , Padrões de Prática Médica/estatística & dados numéricos
6.
BMC Prim Care ; 25(1): 237, 2024 Jul 04.
Artigo em Inglês | MEDLINE | ID: mdl-38965480

RESUMO

BACKGROUND: In 2010, China launched a rural-oriented tuition-waived medical education (RTME) programme to train more general practitioners (GPs) to meet the needs of the rural health workforce. Motivating and maintaining GPs is an important consideration for the shortage in the rural health workforce. This study aimed to investigate job satisfaction and turnover among the first group of rural-oriented tuition-waived medical students (RTMSs) who had completed a three-year compulsory service in Guangxi, as well as the factors affecting RTMSs turnover. METHODS: This study adopted a mixed-method approach. A quantitative survey of 129 RTMSs was analysed (81.6% response rate), and qualitative interviews were conducted with 30 stakeholders, including 18 RTMSs, six administrators of the County Health Bureau, and six administrators of township health centers (THCs). A t-test, chi-square test, Fisher's exact test, and logistic regression analysis were used to examine the quantitative data, and thematic analysis was used to analyse the qualitative data. RESULTS: Among the 129 participants, the turnover rate was high, with 103 RTMSs reporting turnover (79.84%). Interpersonal relationships scored the highest in job satisfaction (3.63 ± 0.64) among RTMSs, while working conditions were rated the lowest (2.61 ± 0.85). Marital status (odds ratio [OR] = 0.236, 95% confidence interval [95%CI] = 0.059-0.953, P = 0.043), only child status (OR = 8.660, 95%CI = 1.714-43.762, P = 0.009), and job return satisfaction (OR = 0.290, 95%CI = 0.090-0.942, P = 0.039) were significantly associated with turnover. Univariate analyses showed that income had a significant influence on turnover, but the relationship gone by multivariable; however it was deemed important in the qualitative study. Qualitative analysis revealed that turnover was influenced by the working atmosphere, effort-reward imbalance, professional competence, and opportunities for training and promotion. CONCLUSIONS: This study provides insights for the policymakers about the priority areas for retaining GPs in rural locations and provides reference values for the retention of GPs in other regions with a shortage of rural health workers. For RTMSs to continue providing services to rural areas, the government should improve their salaries, balance their income and workload, provide more opportunities for training and career promotion, and managers should recognise their efforts and create an optimistic working atmosphere.


Assuntos
Satisfação no Emprego , Reorganização de Recursos Humanos , Serviços de Saúde Rural , Estudantes de Medicina , Humanos , Masculino , Feminino , China , Estudantes de Medicina/psicologia , Estudantes de Medicina/estatística & dados numéricos , Reorganização de Recursos Humanos/estatística & dados numéricos , Adulto , Adulto Jovem , Clínicos Gerais/provisão & distribuição , Clínicos Gerais/psicologia , Inquéritos e Questionários
7.
Pediatr Rheumatol Online J ; 22(1): 63, 2024 Jul 04.
Artigo em Inglês | MEDLINE | ID: mdl-38965620

RESUMO

BACKGROUND: The World Health Organisation Essential Medicines List (WHO EML) guides National Essential Medicines Lists and Standard Treatment Guidelines for clearly identified disease priorities especially in low- and middle-income countries. This study compares the degree to which the basket of medicines recommended for rheumatic diseases in children and young people in National Essential Medicines Lists of countries in the WHO Africa region, corresponds to the 2021 WHO EML and WHO EML for children, as a proxy of availability. METHODS: An online search of the WHO medicines and health technology portal, the Health Ministry websites of the 54 African countries, PUBMED and Google Scholar, with search terms for 'National Essential Medicines List', AND/OR 'standard treatment guidelines' AND/OR 'Lista Nacional de Medicamentos Essenciais' AND/ OR 'Liste Nationale de Medicaments Essentiels' AND Africa AND/OR < Name of African country > was conducted. The number of medicines on the national lists were compared according to a predefined template of medicines; and the percentage similarity calculated. Descriptive statistics were derived using STATA. RESULTS: Forty-seven countries in the WHO Africa region have developed a National Essential Medicines List. Eleven countries do not have any medicines listed for rheumatic diseases. The majority of countries had less than or equal to 50% similarity with the WHO EML for rheumatic disease in children and young people, median 3 medicines (IQR 1- 4). The most common medicines on the national lists from Africa were methotrexate, sulfasalazine and azathioprine, with etanercept available in 6 countries. Seven countries had only one medicine, acetylsalicylic acid listed in the section 'Juvenile Joint diseases'. A multiple linear regression model for the predictors of the number of medicines on the national lists established that 20% of the variability was predicted by health expenditure per capita, socio-demographic index and the availability of rheumatology services (adult and/or paediatric) p = 0.006, with socio-demographic index (p = 0.035, 95% CI 0.64-16.16) and the availability of rheumatology services (p = 0.033, 95% CI 0.13 - 2.90) significant. CONCLUSION: Four countries (8.5%) in Africa have updated their National Essential Medicines Lists to reflect adequate care for children and young people with rheumatic diseases. Moving forward, efforts should focus on aligning available medicines with the WHO EML, and strengthening healthcare policy for rheumatology and pharmaceutical services, for affordable access to care and medicines.


Assuntos
Medicamentos Essenciais , Doenças Reumáticas , Organização Mundial da Saúde , Humanos , Medicamentos Essenciais/provisão & distribuição , Medicamentos Essenciais/uso terapêutico , Doenças Reumáticas/tratamento farmacológico , África , Criança , Adolescente , Antirreumáticos/uso terapêutico , Antirreumáticos/provisão & distribuição
8.
Exp Clin Transplant ; 22(5): 341-350, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38970277

RESUMO

OBJECTIVES: Urologists represent functional alternatives for transplant surgeons, but their involvement is minimal. Evaluating urologists' interests in transplant and identifying associated factors may help to determine whether recruitment of more urological providers is a viable strategy to address transplant surgeon shortages in the United States. MATERIALS AND METHODS: We emailed a 10-question survey to individuals pursuing urology in the United States and collected demographic data, education and training backgrounds, and preferences for proposed integrated residency programs and abbreviated transplant fellowships. We stratified respondents based on transplant interest (yes/no); we made comparisons by using t-tests for continuous variables and Fisher exact tests for categorical variables. We used multivariable logistic regression to identify factors associated with interest in transplant surgery. RESULTS: Of 104 respondents, 98 were included in the final analysis, with 47% indicating a current or prior interest in transplantation. Male respondents were 3.7 times more likely than female respondents to be interested (odds ratio = 4.675; 95% CI, 1.411-15.495; P = .012). Participants aged <30 years were 93% less likely than older participants to be interested in transplantation (odds ratio = 0.071; 95% CI, 0.006-0.779; P = .03). International medical graduates reported higher enthusiasm for transplantation compared with US-trained counterparts (89% vs 42%), with a trend toward significance (P = .06). Nearly all (93%, 43/46) who expressed interest endorsed having an integrated training pathway. Only 70% (32/46) supported an abbreviated fellowship (<24 mo). Lifestyle concerns and insufficient exposure during residency were the most frequently cited reasons for lack of interest. CONCLUSIONS: Compared with male and older urology trainees, female and younger urology trainees were less inclined to pursue transplant surgery. Nonetheless, urologists represent an untapped pool of transplant surgeons. Proposing an integrated training program for urologists and increasing exposure to transplantation during urology residency represent potential strategies to decrease transplant surgeon shortages.


Assuntos
Atitude do Pessoal de Saúde , Escolha da Profissão , Cirurgiões , Urologistas , Humanos , Estudos Transversais , Masculino , Feminino , Urologistas/provisão & distribuição , Urologistas/educação , Adulto , Cirurgiões/educação , Cirurgiões/provisão & distribuição , Estados Unidos , Pessoa de Meia-Idade , Papel do Médico , Transplante de Órgãos , Urologia/educação , Inquéritos e Questionários , Educação de Pós-Graduação em Medicina , Conhecimentos, Atitudes e Prática em Saúde , Procedimentos Cirúrgicos Urológicos/educação , Bolsas de Estudo , Internato e Residência
9.
Exp Clin Transplant ; 22(5): 351-357, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38970278

RESUMO

OBJECTIVES: With the increase in life expectancy and the aging of the population, chronic kidney disease has become increasingly prevalent in our environment. Kidney transplantation remains the gold standard treatment for end-stage renal disease, but the supply of renal grafts has not been able to keep pace with growing demand. Because of this rationale, organ selection criteria have been extended (expanded criteria donation), and alternative donation types, such as donation after circulatory death, have been evaluated. These approaches aim to increase the pool of potential donors, albeit with organs of potentially lower quality. Various forms of donations, including donation after circulatory death, have also undergone assessment. This approach aims to augment the pool of potential donors, notwithstanding the compromised quality of organs associated with such methods. Diverse strategies have been explored to enhance graft function, with one of the most promising being the utilization of pulsatile machine perfusion. MATERIALS AND METHODS: We conducted a retrospective analysis on 28 transplant recipients who met the inclusion criterion of sharing the same donor, wherein one organ was preserved by cold storage and the other by pulsatile machine perfusion. We performed statistical analysis on posttransplant recovery parameters throughout the patients' hospitalization, including admission and discharge phases. RESULTS: Statistically significant differences were noted in delayed graft function (P = .04), blood transfusions requirements, and Clavien-Dindo complications. Furthermore, an overall trend of improvement in discharge parameters and hospital stay was in favor of the pulsatile machine perfusion group. CONCLUSIONS: The use of pulsatile machine perfusion as a method of renal preservation results in graft optimization, leading to earlier recovery and fewer complications compared with cold storage in the context of donation after circulatory death.


Assuntos
Função Retardada do Enxerto , Transplante de Rim , Perfusão , Fluxo Pulsátil , Recuperação de Função Fisiológica , Humanos , Transplante de Rim/efeitos adversos , Estudos Retrospectivos , Resultado do Tratamento , Fatores de Tempo , Masculino , Feminino , Perfusão/métodos , Perfusão/efeitos adversos , Pessoa de Meia-Idade , Adulto , Função Retardada do Enxerto/etiologia , Função Retardada do Enxerto/prevenção & controle , Fatores de Risco , Doadores de Tecidos/provisão & distribuição , Preservação de Órgãos/métodos , Preservação de Órgãos/efeitos adversos , Seleção do Doador , Parada Cardíaca/diagnóstico , Parada Cardíaca/fisiopatologia , Parada Cardíaca/etiologia
10.
Clin Transplant ; 38(7): e15391, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38967586

RESUMO

INTRODUCTION: Given the importance of understanding COVID-19-positive donor incidence and acceptance, we characterize chronological and geographic variations in COVID-19 incidence relative to COVID-19-positive donor acceptance. METHODS: Data on deceased donors and recipients of liver and kidney transplants were obtained from the UNOS database between 2020 and 2023. Hierarchical cluster analysis was used to assess trends in COVID-19-positive donor incidence. Posttransplant graft and patient survival were assessed using Kaplan-Meier curves. RESULTS: From among 38 429 deceased donors, 1517 were COVID-19 positive. Fewer kidneys (72.4% vs. 76.5%, p < 0.001) and livers (56.4% vs. 62.0%, p < 0.001) were used from COVID-19-positive donors versus COVID-19-negative donors. Areas characterized by steadily increased COVID-19 donor incidence exhibit the highest transplantation acceptance rates (92.33%), followed by intermediate (84.62%) and rapidly increased (80.00%) COVID-19 incidence areas (p = 0.016). Posttransplant graft and patient survival was comparable among recipients, irrespective of donor COVID-19 status. CONCLUSIONS: Regions experiencing heightened rates of COVID-19-positive donors are associated with decreased acceptance of liver and kidney transplantation. Similar graft and patient survival is noted among recipients, irrespective of donor COVID-19 status. These findings emphasize the need for adaptive practices and unified medical consensus in navigating a dynamic pandemic.


Assuntos
COVID-19 , Sobrevivência de Enxerto , Transplante de Rim , Transplante de Fígado , SARS-CoV-2 , Doadores de Tecidos , Humanos , COVID-19/epidemiologia , Incidência , Masculino , Feminino , Doadores de Tecidos/provisão & distribuição , Doadores de Tecidos/estatística & dados numéricos , Pessoa de Meia-Idade , Adulto , Obtenção de Tecidos e Órgãos/estatística & dados numéricos , Idoso , Taxa de Sobrevida , Transplantados/estatística & dados numéricos , Estados Unidos/epidemiologia
11.
Indian J Public Health ; 68(2): 233-238, 2024 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-38953811

RESUMO

BACKGROUND: The medical devices industry plays a critical role in public health and requires attention in research and policy. The COVID-19 pandemic exposed a lack of resilience in areas of drugs and vaccines but also in medical products. OBJECTIVES: The study analyzes India's strengths and weaknesses in the trade of medical devices and identifies specific devices where India can attain self-sufficiency and areas where trade is still beneficial. MATERIALS AND METHODS: A set of critical products traded during the COVID-19 pandemic were identified from the World Integrated Trade Solution website at the 6-digit Harmonized System code level. A detailed analysis of exports and imports of medical products at disaggregated 8-digit codes was carried out. RESULTS: During the pandemic, India had a trade surplus in some low-technology-based products such as suture needles, catheters, and cannulae along with X-ray apparatus and electrocardiographs among the medium-tech products. The imports of high-tech devices like in vitro diagnostics almost doubled to meet the surge in demand. The requirement of pulse oximeters, ventilators, and other monitoring devices jumped, and their imports reported an 800% increase from $134 million in 2019-2020 to $1162 million in 2021-2022. Most of India's imports of medical devices come from the top five exporting countries, with the share of the USA and China at 39%-40%. CONCLUSION: There is a need to expand the manufacturing capacity of surgical instruments, consumables and disposables, apart from some high-tech products. The public health care facilities should procure domestically manufactured medical devices and trade with neighbouring countries to reduce import concentration must be prioritised.


Assuntos
COVID-19 , Comércio , Equipamentos e Provisões , SARS-CoV-2 , COVID-19/epidemiologia , Índia , Humanos , Equipamentos e Provisões/provisão & distribuição , Pandemias
12.
Clin Transplant ; 38(7): e15382, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38973768

RESUMO

INTRODUCTION: Adults residing in deprived neighborhoods face various socioeconomic stressors, hindering their likelihood of receiving live-donor kidney transplantation (LDKT) and preemptive kidney transplantation (KT). We quantified the association between residential neighborhood deprivation index (NDI) and the likelihood of LDKT/preemptive KT, testing for a differential impact by race and ethnicity. METHODS: We studied 403 937 adults (age ≥ 18) KT candidates (national transplant registry; 2006-2021). NDI and its 10 components were averaged at the ZIP-code level. Cause-specific hazards models were used to quantify the adjusted hazard ratio (aHR) of LDKT and preemptive KT across tertiles of NDI and its 10 components. RESULTS: Candidates residing in high-deprivation neighborhoods were more likely to be female (40.1% vs. 36.2%) and Black (41.9% vs. 17.7%), and were less likely to receive both LDKT (aHR = 0.66, 95% confidence interval [CI]: 0.64-0.67) and preemptive KT (aHR = 0.60, 95% CI: 0.59-0.62) than those in low-deprivation neighborhoods. These associations differedby race and ethnicity (Black: aHRLDKT = 0.58, 95% CI: 0.55-0.62; aHRpreemptive KT = 0.68, 95% CI: 0.63-0.73; Pinteractions: LDKT < 0.001; Preemptive KT = 0.002). All deprivation components were associated with the likelihood of both LDKT and preemptive KT (except median home value): for example, higher median household income (LDKT: aHR = 1.08, 95% CI: 1.07-1.09; Preemptive KT: aHR = 1.10, 95% CI: 1.08-1.11) and educational attainments (≥high school [LDKT: aHR = 1.17, 95% CI: 1.15-1.18; Preemptive KT: aHR = 1.23, 95% CI: 1.21-1.25]). CONCLUSION: Residence in socioeconomically deprived neighborhoods is associated with a lower likelihood of LDKT and preemptive KT, differentially impacting minority candidates. Identifying and understanding which neighborhood-level socioeconomic status contributes to these racial disparities can be instrumental in tailoring interventions to achieve health equity in LDKT and preemptive KT.


Assuntos
Transplante de Rim , Doadores Vivos , Características da Vizinhança , Humanos , Feminino , Masculino , Doadores Vivos/provisão & distribuição , Pessoa de Meia-Idade , Adulto , Seguimentos , Prognóstico , Características de Residência , Falência Renal Crônica/cirurgia , Fatores Socioeconômicos , Sistema de Registros/estatística & dados numéricos , Fatores de Risco , Adulto Jovem , Adolescente
13.
PLoS One ; 19(7): e0305779, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38985725

RESUMO

Seafood plays an important role in sustainably feeding the world and is one of the most traded food products globally. However sustainability improvements are often focused on its production (e.g., aquaculture, fishing) rather than trade. Here, we quantify the magnitude and extent of global 'redundant two-way' seafood trade-the exchange of the same quantity of the same taxonomic species between two countries-to examine its prevalence and potential implications across the seafood supply chain. We focused on wild-caught seafood trade and found that redundant two-way trade has increased by 43%, between 2000 and 2015, making up 3.2% (7.7 Mt) of global seafood trade during that period. Although most countries were involved in redundant two-way seafood trade (111 of 212 analyzed), the majority occurred between five trade partners: Canada and the United States (15%), Germany and the Netherlands (11.8%); Denmark and Sweden (10.6%); Germany and Denmark (7.1%); and France and Norway (7%). Nearly 50% of redundant trade is made up of just four species including Atlantic herring, Atlantic cod, Skipjack tuna and Atlantic mackerel. While deficiencies in global seafood trade data mask seasonal and product heterogeneity, redundant trade could have implications for meeting conservation and sustainable development goals. Future research should build upon these findings to explore specific environmental, economic, and social implications associated with redundant two-way trade to benefit producers and consumers within the seafood supply chain.


Assuntos
Comércio , Pesqueiros , Alimentos Marinhos , Alimentos Marinhos/economia , Alimentos Marinhos/provisão & distribuição , Pesqueiros/economia , Animais , Canadá , Abastecimento de Alimentos , Conservação dos Recursos Naturais , Alemanha , Estados Unidos , Dinamarca , França , Suécia , Noruega , Internacionalidade
14.
S D Med ; 77(3): 113-118, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38990795

RESUMO

BACKGROUND: As of 2019, South Dakota had only 32 registered dermatologists, one per 27,569 people. Wait times for dermatologic care are affected by factors such as socioeconomic status, provider distribution, and patient to provider ratios. This inaccessibility to care or prolonged wait times may lead to diagnosis and treatment delays as well as disease progression. We hypothesized wait times to see a dermatologist would be longer in rural areas than urban areas in South Dakota. METHODS: Dermatology clinics throughout South Dakota were contacted to obtain wait times. An internet search was conducted to develop a list of dermatology providers. A population of 50,000 or greater defined an urban area and a ratio of four dermatologists per 100,000 people was used as an ideal patient to provider ratio. RESULTS: Overall, 75% of South Dakota's dermatology clinics participated with an equal rural to urban distribution. There was no difference in wait times for new (p=0.787) or established patients (p=0.461) comparing rural and urban clinics. All South Dakota cities with clinics met the goal patient to dermatologist ratio except for Dakota Dunes (included as part of the Sioux City, Iowa, metro population). CONCLUSIONS: The data does not support the hypothesis that wait times for dermatologists would be longer in rural locations than urban locations. Despite adequate dermatologist to patient ratios throughout most of South Dakota, wait times of over six weeks were found at both urban and rural locations, indicating the need for future studies to assess potential solutions for improving timely access to dermatologic care.


Assuntos
Dermatologia , Listas de Espera , South Dakota , Humanos , Dermatologia/estatística & dados numéricos , Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Dermatologistas/estatística & dados numéricos , Dermatologistas/provisão & distribuição , Serviços de Saúde Rural/estatística & dados numéricos , Serviços Urbanos de Saúde/estatística & dados numéricos
18.
BMC Health Serv Res ; 24(1): 802, 2024 Jul 11.
Artigo em Inglês | MEDLINE | ID: mdl-38992687

RESUMO

PURPOSE: To evaluate the availability, cost, affordability of anti-cancer medicines in Nanjing, Jiangsu. METHODS: A longitudinal tracking investigation study was performed to collect information about 24 essential anti-cancer medicines (EAMs) and 17 innovative anti-cancer medicines (IAMs) in 26 healthcare institutions in Nanjing from 2016 to 2020. The availability, cost, drug utilization and affordability of EAMs and IAMs were investigated. RESULTS: The availability of EAMs showed no significant changes in Nanjing, but the availability of IAMs showed a significant increase in 2018 and 2019 and tended to stabilize in 2020. For EAMs, the DDDc(Defined Daily Dose cost) of LPGs (Lowest-Priced Generics) showed no significant changes, and the DDDc of OBs (Originator Brands) and IAMs significantly decreased. The DDDs(Defined Daily Doses) of EAMs (LPGs) showed a decreasing trend since 2016 and rose again in 2019. Overall, the DDDs of EAMs (LPGs) decreased by 25.18% between 2016 and 2020, but the proportion selected for clinical treatment remained at 67.35% in 2020. The DDDs of EAMs (OBs) and IAMs both showed an increasing trend year by year, with a proportional increase of 207.72% and 652.68%, respectively; but the proportion selected for clinical treatment was only 16.09% and 16.56% respectively in 2020. EAMs (LPGs) had good affordability for urban residents but poor affordability for rural residents; the affordability of EAMs (OBs) and IAMs was poor for both urban and rural residents. CONCLUSIONS: There were no significant changes in the availability and cost of EAMs (LPGs), whose lower prices showed better affordability. Although their relative change in drug utilization showed a decreasing trend, they still dominated clinical treatment. Driven by the national drug price negotiation (NDPN) policy, the availability of IAMs was on the rise. It is necessary to further develop and strengthen policies for essential medicines procurement assessment to improve the accessibility of EAMs.


Assuntos
Antineoplásicos , Custos de Medicamentos , Medicamentos Essenciais , Acessibilidade aos Serviços de Saúde , Estudos Longitudinais , Humanos , China , Antineoplásicos/uso terapêutico , Antineoplásicos/economia , Antineoplásicos/provisão & distribuição , Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Medicamentos Essenciais/provisão & distribuição , Medicamentos Essenciais/economia , Custos de Medicamentos/estatística & dados numéricos , Neoplasias/tratamento farmacológico , Drogas em Investigação/economia
19.
Clin Transplant ; 38(7): e15388, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38990103

RESUMO

INTRODUCTION: The 2022 National Academy of Sciences, Engineering, and Medicine report on equity in organ transplantation highlighted limited transparency and accountability for organ offer declines and recommended prioritizing patient engagement in decisions regarding organ offers. Yet, there is no guidance on how to incorporate patients in organ offers. We elected to study the experiences of patients on the waitlist and their perception of a novel Organ Offer Review Card (OORC). METHODS: A prototype OORC was created using Donornet refusal codes. Sixty randomly selected kidney waitlist patients at a single center were asked to participate in a web-based survey focusing on current medical decision-making preferences and perceptions of the prototype OORC. RESULTS: Among the 43 patients reached, 17 (39.5%) completed the survey. Most participants (88.2%) expressed it was important to be involved in the decision-making about organ offers, with 100.0% of respondents wanting to know why an organ was declined. Regarding the prototype OORC, 94.1% thought it helped them understand the factors and priorities considered when selecting an organ, and 88.2% said it increased their belief that their team was acting in their best interest. CONCLUSION: An OORC could increase transparency and communication during the waitlist process while enhancing trust in the transplant team.


Assuntos
Tomada de Decisões , Transplante de Rim , Obtenção de Tecidos e Órgãos , Listas de Espera , Humanos , Obtenção de Tecidos e Órgãos/normas , Masculino , Feminino , Pessoa de Meia-Idade , Inquéritos e Questionários , Doadores de Tecidos/provisão & distribuição , Seguimentos , Prognóstico , Adulto , Participação do Paciente
20.
Clin Transplant ; 38(7): e15397, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-39007406

RESUMO

BACKGROUND: Since the 2018 allocation system change in heart transplantation (HT), ischemic times have increased, which may be associated with peri-operative and post-operative complications. This study aimed to compare ischemia reperfusion injury (IRI) in hearts preserved using ice-cold storage (ICS) and the Paragonix SherpaPak TM Cardiac Transport System (CTS). METHODS: From January 2021 to June 2022, consecutive endomyocardial biopsies from 90 HT recipients were analyzed by a cardiac pathologist in a single-blinded manner: 33 ICS and 57 CTS. Endomyocardial biopsies were performed at three-time intervals post-HT, and the severity of IRI manifesting histologically as coagulative myocyte necrosis (CMN) was evaluated, along with graft rejection and graft function. RESULTS: The incidence of IRI at weeks 1, 4, and 8 post-HT were similar between the ICS and CTS groups. There was a 59.3% statistically significant reduction in CMN from week 1 to 4 with CTS, but not with ICS. By week 8, there were significant reductions in CMN in both groups. Only 1 out of 33 (3%) patients in the ICS group had an ischemic time >240 mins, compared to 10 out of 52 (19%) patients in the CTS group. During the follow-up period of 8 weeks to 12 months, there were no significant differences in rejection rates, formation of de novo donor-specific antibodies and overall survival between the groups. CONCLUSION: The CTS preservation system had similar rates of IRI and clinical outcomes compared to ICS despite longer overall ischemic times. There is significantly more recovery of IRI in the early post operative period with CTS. This study supports CTS as a viable option for preservation from remote locations, expanding the donor pool.


Assuntos
Rejeição de Enxerto , Sobrevivência de Enxerto , Transplante de Coração , Preservação de Órgãos , Humanos , Transplante de Coração/efeitos adversos , Masculino , Feminino , Preservação de Órgãos/métodos , Pessoa de Meia-Idade , Seguimentos , Rejeição de Enxerto/etiologia , Rejeição de Enxerto/patologia , Prognóstico , Adulto , Traumatismo por Reperfusão/etiologia , Traumatismo por Reperfusão/patologia , Criopreservação/métodos , Doadores de Tecidos/provisão & distribuição , Complicações Pós-Operatórias , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA